ClinicalTrials.gg
Not yet recruitingNCT07570797MEDOYEUpdated May 6, 2026

Mentor-Supported Digital Literacy Training

An interventional study of MEDOYE and control grup in eHealth Literacy, Digital Literacy and Migrants, sponsored by Erzincan Binali Yildirim Universitesi. Not yet recruiting. Open to participants aged 18 Years to 74 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-05-06.

Sponsored by Erzincan Binali Yildirim Universitesi · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 74 Years
Sex
All
01

Study summary

Purpose This study is a randomized controlled experimental trial aiming to evaluate the effects of mentoring-based digital literacy training delivered by young migrants on older migrants' eHealth literacy and their ability to seek and verify health information in digital environments. The study will be conducted among young and older Ahiska Turkish migrants living in the Üzümlü district of Erzincan province.

Method The study will be conducted in two phases. In the first phase, young migrants will receive digital literacy training that includes mentoring skills. In the second phase, these individuals will provide training to older migrants.

The sample size has been determined based on a power analysis and will consist of a total of 80 participants. Data will be collected using the eHealth Literacy Scale and the Digital Health Information Seeking and Verification Scale. Data will be analyzed using SPSS software, and appropriate parametric and/or non-parametric tests will be applied.

Training sessions will be conducted in controlled environments, in small groups, and tailored to participants' needs. Participant follow-up will be maintained throughout the process to support the sustainability of the intervention.

Research Hypotheses Primary Hypothesis

  • H0: Mentoring-based digital literacy training delivered by young migrants has no effect on older migrants' levels of eHealth literacy and digital literacy.
  • H1: Mentoring-based digital literacy training delivered by young migrants has a significant effect on older migrants' levels of eHealth literacy and digital literacy.

Secondary Hypothesis

  • H0: Mentoring-based digital literacy training delivered by young migrants has no effect on older migrants' eHealth literacy levels.
  • H2: Mentoring-based digital literacy training delivered by young migrants has a significant effect on older migrants' eHealth literacy levels.

Third Hypothesis

  • H0: Mentoring-based digital literacy training delivered by young migrants has no effect on older migrants' digital literacy levels.
  • H3: Mentoring-based digital literacy training delivered by young migrants has a significant effect on older migrants' digital literacy levels.
02

Conditions studied

  • eHealth Literacy
  • Digital Literacy
  • Migrants

Browse trials for

Keywords

  • Digital literacy, E-health literacy, Migrants, Mentorship, Older adults
03

In context

Literacy

201 studies on the registry are indexed under Literacy; 69 are open to participants now.

This study's planned enrollment of 80 is below the median of 124 across 170 interventional studies indexed under Literacy.

Browse Literacy studies →

Lead sponsor

Erzincan Binali Yildirim Universitesi is the lead sponsor of 23 studies on the registry; 10 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 74 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:Young Participants (Migrants)

  • Aged between 18-64 years
  • Being a migrant
  • Literate (able to read and write)
  • Able to speak and write in Turkish
  • Able to communicate verbally
  • Having access to internet at home or workplace
  • Having access to a smartphone or a phone that belongs to a family member and can be used by the participant
  • Able to use the internet
  • Willing to participate in the study
  • Willing to act as a mentor

Older Participants (Migrants)

  • Aged between 65-74 years
  • Literate in Turkish
  • Having internet access at home
  • Using a smartphone

Exclusion Criteria:

Young Participants (Migrants)

  • Presence of visual or hearing impairments that would prevent participation in the study
  • Having a physical or mental health condition that may interfere with participation
  • Inability to attend training sessions regularly during the intervention period

Older Participants (Migrants)

  • Presence of visual or hearing impairments that would prevent participation in the study
  • Inability to attend training sessions regularly during the intervention period
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    MEDOYE

    Participants in the experimental group will receive a mentoring-based digital literacy training program delivered by young migrants. The intervention will consist of nine sessions conducted twice a week, each lasting 45-90 minutes. The training will include mentoring skills development, digital literacy education, and interactive teaching methods such as role-playing, demonstrations, and small group discussions. Participants will practice mentoring in pairs, with role switching and partner changes across sessions. After each session, young participants will provide digital literacy support to older migrants in their households. Pre- and post-test assessments will be conducted using the eHealth Literacy Scale and the Digital Health Information Seeking and Verification Scale.

    Other: MEDOYE

  • Active comparator
    control grubu

    Other: control grup

Interventions

  • OtherMEDOYE

    Participants who agree to take part in the study will be enrolled in a mentoring-based training program. The training content will include group process management, warm-up activities, computer-assisted instruction (PowerPoint presentations), verbal instruction, role-playing, demonstration and practice, small group discussions, and question-answer techniques. A total of nine training sessions will be conducted twice a week, each lasting 45-90 minutes. Short breaks not exceeding 15 minutes will be provided based on participants' needs and feedback. To enhance mentoring skills, participants will be divided into pairs and will practice mentoring each other. Roles will be switched after each session. In subsequent sessions, participants will change partners, allowing them to practice mentoring with different individuals. These mentoring practices will be observed by the researchers. The schedule of the training sessions will be arranged according to the availability and preferences of the

  • Othercontrol grup

    Participants in the control group will receive no intervention during the study period. At baseline, participants will complete the pre-test assessments, including the Personal Information Form, the eHealth Literacy Scale, and the Digital Health Information Seeking and Verification Scale. After the completion of the experimental group intervention, post-test assessments will be administered. Following the study, digital literacy training will also be provided to control group participants.

06

What researchers measure

Primary outcomes

  1. eHealth Literacy Scale

    This scale was developed by C. Norman and H. Skinner in 2006 to measure eHealth literacy. The Turkish validity and reliability study was conducted by Tamer Gencer in 2017. The eHealth Literacy Scale consists of 8 items. A 5-point Likert-type scale is used for scoring the items, ranging from "strongly disagree," "disagree," "neutral," "agree," to "strongly agree." The total score obtained from the scale reflects the participant's level of eHealth literacy. The minimum possible score is 8, and the maximum score is 40. Higher scores indicate a higher level of eHealth literacy. The internal consistency reliability coefficient of the scale was calculated as 0.86.

    Time frame: Baseline and 6 weeks after intervention

Secondary outcomes

  1. Digital Health Information Seeking and Verification Scale

    This scale was developed by Çömlekçi MF and Bozkanat E in 2021 to measure health-related information seeking, digital health information seeking, and digital verification behaviors. A 5-point Likert-type attitude scale is used for scoring the items, ranging from 1 ("never") to 5 ("always"). The total score of the scale ranges from 1 to 5. Higher scores indicate more positive outcomes. There are no reverse-coded items in the scale. Çömlekçi and Bozkanat reported the reliability of the scale with a Cronbach's alpha coefficient greater than 0.758. The scale can be applied to digital and media users aged 18 years and older. It consists of three sub-dimensions: F1: Web 1.0 and Health Information Seeking F2: Web 2.0 and Digital Health Information Seeking F3: Digital Verification Higher scores in all sub-dimensions indicate more positive outcomes.

    Time frame: Baseline and 6 weeks after intervention

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2026; primary completion for Sep 2026, 2 months later.

Of 115 non-industry interventional studies with no phase under Literacy, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 20. This study's planned 2 months is below that.

Counting every sponsor, half of 117 studies reached it within 11 months; a quarter within 4 and three quarters within 19.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 30, 2026
First posted
May 6, 2026
StartEst.
Jul 1, 2026
Primary completionEst.
Sep 30, 2026
CompletionEst.
Feb 25, 2027
Last update
May 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07570797
Lead sponsor
Erzincan Binali Yildirim Universitesi
Responsible party
Ezgi DEMİRTÜRK SELÇUK (Assistant Professor, Erzincan Binali Yildirim Universitesi) — Principal investigator
First posted
May 6, 2026
Start date
Jul 1, 2026 (estimated)
Primary completion
Sep 30, 2026 (estimated)
Completion
Feb 25, 2027 (estimated)
Last update
May 6, 2026

Study contacts

Ezgi Demirtürk Selçuk, PhD
Contact
ezgi.selcuk@erzincan.edu.tr
+905448502161

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion